List of Tables
Table 1. Global Female Sexual Dysfunction Treatment Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Female Sexual Dysfunction Treatment Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Female Sexual Dysfunction Treatment Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Female Sexual Dysfunction Treatment Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Female Sexual Dysfunction Treatment Drug Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Female Sexual Dysfunction Treatment Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Female Sexual Dysfunction Treatment Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Female Sexual Dysfunction Treatment Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Female Sexual Dysfunction Treatment Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Female Sexual Dysfunction Treatment Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Female Sexual Dysfunction Treatment Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Female Sexual Dysfunction Treatment Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Female Sexual Dysfunction Treatment Drug Sales by Region (K Units), 2021–2026
Table 18. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Region (2021–2026)
Table 19. Global Female Sexual Dysfunction Treatment Drug Sales by Region (K Units), 2027–2032
Table 20. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Region (2027–2032)
Table 21. Global Female Sexual Dysfunction Treatment Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Female Sexual Dysfunction Treatment Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Female Sexual Dysfunction Treatment Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Female Sexual Dysfunction Treatment Drug Sales by Country (K Units), 2021–2026
Table 27. North America Female Sexual Dysfunction Treatment Drug Sales by Country (K Units), 2027–2032
Table 28. North America Female Sexual Dysfunction Treatment Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Female Sexual Dysfunction Treatment Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Female Sexual Dysfunction Treatment Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Female Sexual Dysfunction Treatment Drug Sales by Country (K Units), 2021–2026
Table 32. Europe Female Sexual Dysfunction Treatment Drug Sales by Country (K Units), 2027–2032
Table 33. Europe Female Sexual Dysfunction Treatment Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Female Sexual Dysfunction Treatment Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Female Sexual Dysfunction Treatment Drug Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Female Sexual Dysfunction Treatment Drug Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Female Sexual Dysfunction Treatment Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Female Sexual Dysfunction Treatment Drug Sales by Country (K Units), 2021–2026
Table 42. Latin America Female Sexual Dysfunction Treatment Drug Sales by Country (K Units), 2027–2032
Table 43. Latin America Female Sexual Dysfunction Treatment Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Female Sexual Dysfunction Treatment Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Female Sexual Dysfunction Treatment Drug Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Female Sexual Dysfunction Treatment Drug Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) by Type (2021–2026)
Table 51. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) by Type (2027–2032)
Table 52. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2021–2026)
Table 53. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2027–2032)
Table 54. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Type (2021–2026)
Table 59. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Type (2027–2032)
Table 60. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) by Application (2021–2026)
Table 61. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) by Application (2027–2032)
Table 62. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2021–2026)
Table 63. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2027–2032)
Table 64. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Application (2021–2026)
Table 69. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Female Sexual Dysfunction Treatment Drug Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Teva Pharmaceuticals Company Information
Table 76. Teva Pharmaceuticals Description and Business Overview
Table 77. Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product
Table 79. Teva Pharmaceuticals Recent Developments/Updates
Table 80. Duchesnay Company Information
Table 81. Duchesnay Description and Business Overview
Table 82. Duchesnay Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Duchesnay Female Sexual Dysfunction Treatment Drug Product
Table 84. Duchesnay Recent Developments/Updates
Table 85. Sprout Pharmaceuticals Company Information
Table 86. Sprout Pharmaceuticals Description and Business Overview
Table 87. Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product
Table 89. Sprout Pharmaceuticals Recent Developments/Updates
Table 90. Cosette Pharmaceuticals Company Information
Table 91. Cosette Pharmaceuticals Description and Business Overview
Table 92. Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product
Table 94. Cosette Pharmaceuticals Recent Developments/Updates
Table 95. Lupin Company Information
Table 96. Lupin Description and Business Overview
Table 97. Lupin Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Lupin Female Sexual Dysfunction Treatment Drug Product
Table 99. Lupin Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Female Sexual Dysfunction Treatment Drug Distributors List
Table 103. Female Sexual Dysfunction Treatment Drug Customers List
Table 104. Female Sexual Dysfunction Treatment Drug Market Trends
Table 105. Female Sexual Dysfunction Treatment Drug Market Drivers
Table 106. Female Sexual Dysfunction Treatment Drug Market Challenges
Table 107. Female Sexual Dysfunction Treatment Drug Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Female Sexual Dysfunction Treatment Drug
Figure 2. Global Female Sexual Dysfunction Treatment Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Female Sexual Dysfunction Treatment Drug Market Share by Type: 2025 & 2032
Figure 4. Estrogen Therapy Product Picture
Figure 5. Ospemifene Product Picture
Figure 6. Flibanserin Product Picture
Figure 7. Bremelanotide Product Picture
Figure 8. Others Product Picture
Figure 9. Global Female Sexual Dysfunction Treatment Drug Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Female Sexual Dysfunction Treatment Drug Market Share by Application: 2025 & 2032
Figure 11. Hospital Pharmacies
Figure 12. Private Clinics
Figure 13. Retail Pharmacies
Figure 14. E-Commerce (B2B)
Figure 15. E-Commerce (B2C)
Figure 16. Global Female Sexual Dysfunction Treatment Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Female Sexual Dysfunction Treatment Drug Market Size (US$ Million), 2021–2032
Figure 18. Global Female Sexual Dysfunction Treatment Drug Sales (K Units), 2021–2032
Figure 19. Global Female Sexual Dysfunction Treatment Drug Average Price (US$/Unit), 2021–2032
Figure 20. Female Sexual Dysfunction Treatment Drug Report Years Considered
Figure 21. Female Sexual Dysfunction Treatment Drug Sales Share by Manufacturers in 2025
Figure 22. Global Female Sexual Dysfunction Treatment Drug Revenue Share by Manufacturers in 2025
Figure 23. Top 5 and Top 10 Global Female Sexual Dysfunction Treatment Drug Players: Market Share by Revenue in Female Sexual Dysfunction Treatment Drug in 2025
Figure 24. Female Sexual Dysfunction Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 25. Global Female Sexual Dysfunction Treatment Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 26. North America Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2021–2032)
Figure 27. North America Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2021–2032)
Figure 28. United States Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Canada Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Europe Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2021–2032)
Figure 31. Europe Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2021–2032)
Figure 32. Germany Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. France Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. U.K. Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Italy Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Russia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Asia Pacific Female Sexual Dysfunction Treatment Drug Sales Market Share by Region (2021–2032)
Figure 38. Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue Market Share by Region (2021–2032)
Figure 39. China Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Japan Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. South Korea Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. India Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Australia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. China Taiwan Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Southeast Asia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Latin America Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2021–2032)
Figure 47. Latin America Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2021–2032)
Figure 48. Mexico Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Brazil Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Argentina Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Colombia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Middle East and Africa Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2021–2032)
Figure 53. Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2021–2032)
Figure 54. Turkey Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Saudi Arabia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. UAE Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Global Sales Market Share of Female Sexual Dysfunction Treatment Drug by Type (2021–2032)
Figure 58. Global Revenue Market Share of Female Sexual Dysfunction Treatment Drug by Type (2021–2032)
Figure 59. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Type (2021–2032)
Figure 60. Global Sales Market Share of Female Sexual Dysfunction Treatment Drug by Application (2021–2032)
Figure 61. Global Revenue Market Share of Female Sexual Dysfunction Treatment Drug by Application (2021–2032)
Figure 62. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Application (2021–2032)
Figure 63. Female Sexual Dysfunction Treatment Drug Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
